|
1 Indications And Usage Cinvanti, In Combination With Other Antiemetic Agents, Is Indicated In Adults For The Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin As A Single-Dose Regimen. Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec) As A Single-Dose Regimen. Nausea And Vomiting Associated With Initial And Repeat Courses Of Mec As A 3-Day Regimen. Limitations Of Use Cinvanti Has Not Been Studied For The Treatment Of Established Nausea And Vomiting. Cinvanti Is A Substance P/neurokinin-1 (Nk 1 ) Receptor Antagonist, Indicated In Adults, In Combination With Other Antiemetic Agents, For The Prevention Of: Acute And Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Highly Emetogenic Cancer Chemotherapy (Hec) Including High-Dose Cisplatin As A Single-Dose Regimen. ( 1 ) Delayed Nausea And Vomiting Associated With Initial And Repeat Courses Of Moderately Emetogenic Cancer Chemotherapy (Mec) As A Single-Dose Regimen. ( 1 ) Nausea And Vomiting Associated With Initial And Repeat Courses Of Mec As A 3-Day Regimen. ( 1 ) Limitations Of Use: Cinvanti Has Not Been Studied For Treatment Of Established Nausea And Vomiting. ( 1 )
|